↓ Skip to main content

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

Overview of attention for article published in Molecular Cancer, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent
1 patent
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
259 Dimensions

Readers on

mendeley
131 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Published in
Molecular Cancer, April 2008
DOI 10.1186/1476-4598-7-35
Pubmed ID
Authors

Alexandros Laios, Sharon O'Toole, Richard Flavin, Cara Martin, Lynne Kelly, Martina Ring, Stephen P Finn, Ciara Barrett, Massimo Loda, Noreen Gleeson, Tom D'Arcy, Eamonn McGuinness, Orla Sheils, Brian Sheppard, John O' Leary

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs that negatively regulate gene expression by binding to target mRNAs. miRNAs have not been comprehensively studied in recurrent ovarian cancer, yet an incurable disease.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 3%
Malaysia 1 <1%
Netherlands 1 <1%
Unknown 125 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 23%
Researcher 29 22%
Student > Master 20 15%
Professor > Associate Professor 11 8%
Student > Doctoral Student 7 5%
Other 22 17%
Unknown 12 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 56 43%
Biochemistry, Genetics and Molecular Biology 26 20%
Medicine and Dentistry 20 15%
Chemistry 3 2%
Computer Science 2 2%
Other 8 6%
Unknown 16 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2018.
All research outputs
#3,486,216
of 17,355,315 outputs
Outputs from Molecular Cancer
#163
of 1,372 outputs
Outputs of similar age
#59,864
of 297,361 outputs
Outputs of similar age from Molecular Cancer
#8
of 36 outputs
Altmetric has tracked 17,355,315 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,372 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,361 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.